Rivian Hints at New R2 Variants as Production Ramps Up Ahead of 2027 Launch 
Hua Hong Semiconductor Stock Surges to Multi-Year High Amid AI Boom 
Strategy Reports Q1 Loss as Bitcoin Holdings Trigger $14.46 Billion Unrealized Hit 
Orsted Q1 EBITDA Beats Expectations Despite U.S. Impairments 
AMD Q1 Earnings Surge on AI Demand, Stock Jumps After Strong Guidance 
Shell Q1 Profit Surges to Two-Year High as Dividend Rises Despite War-Driven Debt Pressure 
Hugo Boss Beats Q1 Profit Expectations Despite Market Headwinds 
Palantir Reports Record Growth, Raises 2026 Revenue Outlook Above Expectations 
Intel Emerges as Key Contender in Apple’s Chip Manufacturing Strategy Shift 
BHP Attracts AI-Focused Investors as Copper Demand Surges 
Pinterest Stock Surges After Strong Q1 2026 Earnings Beat Expectations 
Philips Reaffirms 2026 Outlook After Strong Q1 Sales and Margin Beat 
Strategy Hints at Bitcoin Sales to Cover Dividends After Massive Q1 Loss 
Volvo Car Sales Drop 10% in Early 2026 Despite Growth in Electric Vehicles 
Arm Stock Drops Despite Strong AI Chip Demand and Earnings Beat 
BMW Keeps 2026 Outlook Despite 25% Profit Drop Amid Tariff Pressure 
UOB Q1 Profit Meets Expectations as Loan Growth Offsets Lower Interest Rates 
NEW YORK, May 01, 2018 -- NanoVibronix, Inc., (NASDAQ:NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that it will be presenting at the 3rd annual Disruptive Growth & Healthcare Conference in New York City on Tuesday, May 8th at 1:45 PM, Eastern Time. Chief Executive Officer of NanoVibronix, Brian Murphy, will be presenting, as well as meeting with investors. Mr. Murphy will also be presenting on the Disruptive Pain Management Panel at 3:00 PM on May 8th.
The 2018 Disruptive Growth & Healthcare Conference will offer investors the opportunity to discover life science companies focusing on solutions for unmet medical needs and growth companies with disruptive technologies and business models.
About NanoVibronix
NanoVibronix Inc. (NASDAQ:NAOV) is a medical device company headquartered in Elmsford, NY with research and development in Nesher, Israel, that is focused on developing medical devices utilizing its proprietary and patented low intensity surface acoustic wave technology. The company's technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including the disruption of biofilms and bacteria colonization, as well as providing pain relief. The devices can be administered at home, without the assistance of medical professionals. The company's primary products include PainShield®, UroShield™ and WoundShield™. Additional information about the company is available at: www.nanovibronix.com.
About RHK Capital:
Advisory Group Equity Services, Ltd. (dba RHK Capital) was founded in 1984. RHK Capital is a boutique investment banking firm specializing in small to medium-sized transactions. RHK is led by a management team with extensive financial industry experience and a desire to provide companies and individuals with the tools and expertise to accomplish their financial goals. In addition to investment banking, RHK has grown to include businesses in general securities, emerging market securities, distressed and high yield debt securities, investment management, mortgages, and business lending. As a division of Advisory Group Equity Services (AGES), all securities are offered through Advisory Group Equity Services Ltd., a registered broker-dealer, member of the Financial Industry Regulatory Authority and the Securities Investor Protection Corporation.
Investor Contacts:
Crescendo Communications
[email protected]
(212) 671-1021
